Dr. Yıldız Tütüncü graduated from Istanbul University, Cerrahpasa Medical Faculty, Department of Biomedical Sciences. She earned her M.S. and Ph.D. degree in the field of Immunology at Istanbul University. Dr. Tütüncü received Associate Professor degree in the field of Basic Immunology. Dr. Tütüncü worked at Istanbul Medical Faculty, Department of Internal Diseases, Divison of Endocrinology and Metabolism Diseases and Aziz Sancar Experimental Medical Research Institute, Department of Immunology. Dr. Tütüncü worked as a researcher in the MEDIGENE (EU 7. FP) project at the INSERM Molecular Endocrinology Laboratory in Montpellier, France. Dr. Tütüncü worked as a researcher in several international and national projects supported by the European Union, TUBITAK, University Scientific Research Projects, and the pharmaceutical industry. Dr. Tütüncü research interests include transplant immunology, especially liver transplantation; immunometabolism of innate immune system cells in individuals with metabolic syndrome, diabetes mellitus, progressive familial intrahepatic cholestasis, immune and inflammatory pathways in the pathogenesis of non-alcoholic fatty liver disease.


Selected Publications:

Fine-scale haplotype mapping of MUT, AACS, SLC6A15 and PRKCA genes indicates association with insulin resistance of metabolic syndrome and relationship with branched chain amino acid metabolism or regulation. Haydar S, Grigorescu F, Vintilă M, Cogne Y, Lautier C, Tutuncu Y, et al. PLoS One, 2019 Mar 26;14(3):e0214122. doi: 10.1371/journal.pone.0214122. eCollection 2019.

A Comparison of hs-CRP Levels in New Diabetes Groups Diagnosed Based on FPG, 2-hPG, or HbA1c Criteria. Tutuncu Y, Satman I, Celik S, Dinccag N, Karsidag K, Telci A, Genc S, Issever H, Tuomilehto J, Omer B., J Diabetes Res. 2016; 2016:5827041. doi: 10.1155/2016/5827041.

Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults. Satman I, Omer B, Tutuncu Y, Kalaca S, Gedik S, Dinccag N, Karsidag K, Genc S, Telci A, Canbaz B, Turker F, Yilmaz T, Cakir B, Tuomilehto J; TURDEP-II Study Group. Eur J Epidemiol.;28(2):169-80, 2013.

Effect of ramipril on the incidence of diabetes. DREAM Trial Investigators, Bosch J, Yusuf S, Gerstein HC, Pogue J, Sheridan P, Dagenais G, Diaz R, Avezum A et al. (Site investigators by country: Turkey: Dinccag N, Kaya S, Oglagu Z, Tutuncu Y)  N Engl J Med 355(15):1551-62, 2006.

Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomized controlled trial. DREAM Trial Investigators, Gerstein HC, Yusuf S, Bosch J, Pogue J, Sheridan P, et al.(Site investigators by country: Turkey: Dinccag N, Kaya S, Oglagu Z, Tutuncu Y)  Lancet 368(9541):1096-105, 2006.

Population-based Study of Diabetes and Risk Characteristics in Turkey: results of the Turkish Diabetes Epidemiology Study (TURDEP). Satman İ, Yılmaz T, Sengül A, Salman S, Salman F, Uygur S, Bastar I, Tutuncu Y, Sargın M, Dinccag N, Karsidag K, Kalaca S, Ozcan C, King H, and the TURDEP Group: Diabetes Care 25: 1551-1556, 2002.